Journal article icon

Journal article

Novel costimulators in the immune gene therapy of cancer.

Abstract:

One of the major goals of cancer immunotherapy is the induction of tumour-specific T-lymphocyte responses that will be effective in the rejection of established tumours. The prospects for such therapy rely on the identification of tumour antigens, and although there is persuasive evidence for the presence of such antigens,1,2 the occurrence of the disease does illustrate that the immune system is at least, on some occasions, unable to recognise and destroy these targets. Tumour antigens may b...

Expand abstract
Publication status:
Published

Actions


Journal:
Cancer gene therapy More from this journal
Volume:
3
Issue:
3
Pages:
202-214
Publication date:
1996-01-01
EISSN:
1476-5500
ISSN:
0929-1903

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP